Smoking and IPMN malignant progression

R. A. Carr, A. M. Roch, K. Shaffer, S. Aboudi, C. M. Schmidt, John DeWitt, E. P. Ceppa, Michael House, Nicholas Zyromski, Attila Nakeeb, C. Schmidt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Patients with intraductal papillary mucinous neoplasm (IPMN) are at risk for invasive pancreatic cancer. We aim to characterize the impact of smoking on IPMN malignant progression. Methods: Patients undergoing pancreatic resection for IPMN (1991-2015) were retrospectively reviewed using a prospectively collected database. Results: Of 422 patients identified, 324 had complete data for analysis; 55% were smokers. Smoking status did not impact IPMN malignant progression (smokers/non-smokers: 22%/18% invasive grade; p = 0.5).Smokers were younger than non-smokers at the time of IPMN diagnosis (63 versus 68 years; p = 0.001). This association also held in the invasive IPMN subgroup (65 versus 72 years, p = 0.01). Despite this observation, rate of symptoms at diagnosis, cancer stage, and median survival were the same between smokers and non-smokers. Conclusion: Although smoking is not associated with IPMN malignant progression, invasive IPMN is diagnosed at a younger age in smokers. These data suggest tobacco exposure may accelerate IPMN malignant progression.

Original languageEnglish (US)
JournalAmerican Journal of Surgery
DOIs
StateAccepted/In press - Jul 25 2016

Fingerprint

Smoking
Neoplasms
Pancreatic Neoplasms
Tobacco
Databases
Survival

Keywords

  • Age
  • Intraductal papillary mucinous neoplasm (IPMN)
  • Smoking

ASJC Scopus subject areas

  • Surgery

Cite this

Smoking and IPMN malignant progression. / Carr, R. A.; Roch, A. M.; Shaffer, K.; Aboudi, S.; Schmidt, C. M.; DeWitt, John; Ceppa, E. P.; House, Michael; Zyromski, Nicholas; Nakeeb, Attila; Schmidt, C.

In: American Journal of Surgery, 25.07.2016.

Research output: Contribution to journalArticle

Carr, R. A. ; Roch, A. M. ; Shaffer, K. ; Aboudi, S. ; Schmidt, C. M. ; DeWitt, John ; Ceppa, E. P. ; House, Michael ; Zyromski, Nicholas ; Nakeeb, Attila ; Schmidt, C. / Smoking and IPMN malignant progression. In: American Journal of Surgery. 2016.
@article{ac0eb065b67c43bfbc787b7d2df6fb22,
title = "Smoking and IPMN malignant progression",
abstract = "Background: Patients with intraductal papillary mucinous neoplasm (IPMN) are at risk for invasive pancreatic cancer. We aim to characterize the impact of smoking on IPMN malignant progression. Methods: Patients undergoing pancreatic resection for IPMN (1991-2015) were retrospectively reviewed using a prospectively collected database. Results: Of 422 patients identified, 324 had complete data for analysis; 55{\%} were smokers. Smoking status did not impact IPMN malignant progression (smokers/non-smokers: 22{\%}/18{\%} invasive grade; p = 0.5).Smokers were younger than non-smokers at the time of IPMN diagnosis (63 versus 68 years; p = 0.001). This association also held in the invasive IPMN subgroup (65 versus 72 years, p = 0.01). Despite this observation, rate of symptoms at diagnosis, cancer stage, and median survival were the same between smokers and non-smokers. Conclusion: Although smoking is not associated with IPMN malignant progression, invasive IPMN is diagnosed at a younger age in smokers. These data suggest tobacco exposure may accelerate IPMN malignant progression.",
keywords = "Age, Intraductal papillary mucinous neoplasm (IPMN), Smoking",
author = "Carr, {R. A.} and Roch, {A. M.} and K. Shaffer and S. Aboudi and Schmidt, {C. M.} and John DeWitt and Ceppa, {E. P.} and Michael House and Nicholas Zyromski and Attila Nakeeb and C. Schmidt",
year = "2016",
month = "7",
day = "25",
doi = "10.1016/j.amjsurg.2016.10.033",
language = "English (US)",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Smoking and IPMN malignant progression

AU - Carr, R. A.

AU - Roch, A. M.

AU - Shaffer, K.

AU - Aboudi, S.

AU - Schmidt, C. M.

AU - DeWitt, John

AU - Ceppa, E. P.

AU - House, Michael

AU - Zyromski, Nicholas

AU - Nakeeb, Attila

AU - Schmidt, C.

PY - 2016/7/25

Y1 - 2016/7/25

N2 - Background: Patients with intraductal papillary mucinous neoplasm (IPMN) are at risk for invasive pancreatic cancer. We aim to characterize the impact of smoking on IPMN malignant progression. Methods: Patients undergoing pancreatic resection for IPMN (1991-2015) were retrospectively reviewed using a prospectively collected database. Results: Of 422 patients identified, 324 had complete data for analysis; 55% were smokers. Smoking status did not impact IPMN malignant progression (smokers/non-smokers: 22%/18% invasive grade; p = 0.5).Smokers were younger than non-smokers at the time of IPMN diagnosis (63 versus 68 years; p = 0.001). This association also held in the invasive IPMN subgroup (65 versus 72 years, p = 0.01). Despite this observation, rate of symptoms at diagnosis, cancer stage, and median survival were the same between smokers and non-smokers. Conclusion: Although smoking is not associated with IPMN malignant progression, invasive IPMN is diagnosed at a younger age in smokers. These data suggest tobacco exposure may accelerate IPMN malignant progression.

AB - Background: Patients with intraductal papillary mucinous neoplasm (IPMN) are at risk for invasive pancreatic cancer. We aim to characterize the impact of smoking on IPMN malignant progression. Methods: Patients undergoing pancreatic resection for IPMN (1991-2015) were retrospectively reviewed using a prospectively collected database. Results: Of 422 patients identified, 324 had complete data for analysis; 55% were smokers. Smoking status did not impact IPMN malignant progression (smokers/non-smokers: 22%/18% invasive grade; p = 0.5).Smokers were younger than non-smokers at the time of IPMN diagnosis (63 versus 68 years; p = 0.001). This association also held in the invasive IPMN subgroup (65 versus 72 years, p = 0.01). Despite this observation, rate of symptoms at diagnosis, cancer stage, and median survival were the same between smokers and non-smokers. Conclusion: Although smoking is not associated with IPMN malignant progression, invasive IPMN is diagnosed at a younger age in smokers. These data suggest tobacco exposure may accelerate IPMN malignant progression.

KW - Age

KW - Intraductal papillary mucinous neoplasm (IPMN)

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=85010192551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010192551&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2016.10.033

DO - 10.1016/j.amjsurg.2016.10.033

M3 - Article

C2 - 28129918

AN - SCOPUS:85010192551

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

ER -